Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMED.L Regulatory News (MED)

  • There is currently no data for MED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Opening of Hong Kong office

21 Feb 2018 07:00

RNS Number : 4502F
Medaphor Group PLC
21 February 2018
 

MedaPhor Group plc

("MedaPhor" or the "Group" or the "Company")

 

Opening of Hong Kong office

 

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that it has opened an office in Hong Kong to facilitate the Group's established reseller network and growing customer base in the Asia-Pacific (APAC) region.

 

The Group now has 18 active reseller partners in this region selling the ScanTrainer, HeartWorks and new BodyWorks Eve simulation portfolio into hospitals and university teaching schools.

 

The new Hong Kong office will support and aim to expand reseller sales, marketing and customer relations across the APAC region and especially in the growing Chinese simulation market.

 

The Company has appointed a local Channel and Product Support Manager, Victor Kwan, to be permanently based out of the Hong Kong office. Victor brings with him over 10 years of experience working in product marketing and management, seven of which were spent in the medical simulation industry.

 

Stuart Gall, Chief Executive Officer at MedaPhor, comments:

"We now have a well-established reseller channel in APAC and are looking to cement our presence in the region. With its central location and excellent transport links, our new Hong Kong office will enable us to have a full-time local presence in these important and growing markets, as we look to continue the expansion and growth in the APAC ultrasound software and simulation market."

 

Enquiries:

 

MedaPhor Group plc

investors.medaphor.com

Stuart Gall, CEO

Ian Whittaker, COO

Tel: +44 (0)29 2075 6534

 

 

Cenkos Securities

Tel: +44 (0)20 7397 8900

Camilla Hume/Bobbie Hilliam (Nominated Advisor)

 

Michael Johnson / Julian Morse (Corporate Broking)

 

 

 

Walbrook PR

Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com

Paul McManus / Anna Dunphy

Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876 741 001

 

 

About MedaPhor (investors.medaphor.com)

 

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, develops artificial intelligence-based clinical image analysis software tools, augmented reality-based needle guidance software and advanced hi-fidelity haptic and manikin-based training simulators for medical practitioners.

 Based in Cardiff and Oxford in the UK and Atlanta in the US, MedaPhor is split into two divisions:

 Intelligent Ultrasound Simulation and Training

 

Focuses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer OBGYN and General Medical simulator training platform, the HeartWorks Echocardiography simulator platform and BodyWorks Eve the Point of Care Ultrasound (PoCUS) simulator. Over 500 MedaPhor simulators have been sold to over 300 medical institutions in over 30 countries around the world.

Intelligent Ultrasound Clinical Support

 

Focuses on augmented reality and deep-learning based algorithms to make ultrasound machines smarter and more accessible. Products in development include ScanNav which uses machine-learning based algorithms to automatically identify and grade ultrasound images to provide scan assessment and audit of obstetric scanning. NeedleGuide aims to simplify ultrasound-guided needling by using deep learning and augmented reality to provide the user with pathway guidance and automated tracking for a range of medical procedures.

 

Some products in the pipeline may require US FDA approval, as such this material should be considered informational only and does not constitute an offer to sell, or infer, claims or benefits.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDBLFLVLFXBBK
Date   Source Headline
27th Aug 20147:00 amRNSAdmission and First Day of Dealings
28th Nov 20083:32 pmRNSAppt of Administrator & Resignation of Adviser
20th Nov 20087:30 amRNSSuspension - MicroEmissive Displays Group PLC
20th Nov 20087:30 amRNSIntention to appoint administrators
19th Nov 200811:16 amRNSEPT Disclosure
18th Nov 200812:32 pmRNSRule 8.3- Microemissive Displays Group PLC
31st Oct 20082:36 pmRNSEPT Disclosure
29th Oct 20087:59 amRNSEPT Disclosure
28th Oct 20081:15 pmBUSRule 8.3 - Microemissive Displays Group
27th Oct 20089:10 amRNSEPT Disclosure
24th Oct 20088:04 amRNSEPT Disclosure
30th Sep 200811:19 amRNSInterim Results - Replacement
30th Sep 20087:00 amRNSInterim Results
25th Sep 200811:07 amRNSEPT Disclosure
23rd Sep 20087:27 amRNSEPT Disclosure
15th Sep 20088:31 amRNSEPT Disclosure
11th Sep 20082:25 pmRNSEPT Disclosure
8th Sep 20088:26 amRNSEPT Disclosure
4th Sep 20083:58 pmRNSHolding(s) in Company
4th Sep 200810:15 amRNSRule 8.3- MicroEmissive Displ
4th Sep 20088:04 amRNSEPT Disclosure
3rd Sep 20087:53 amRNSEPT Disclosure
2nd Sep 20087:31 amRNSEPT Disclosure
1st Sep 20088:41 amRNSEPT Disclosure
22nd Aug 20083:34 pmRNSEPT Disclosure
21st Aug 200812:32 pmRNSRule 8.3- Microemissive Displ
20th Aug 20087:50 amRNSEPT Disclosure
19th Aug 20087:55 amRNSEPT Disclosure
18th Aug 20084:55 pmRNSRule 8.3- MicroEmissive Displ
18th Aug 20084:54 pmRNSRule 8.3- MicroEmissive Displ
18th Aug 200811:16 amRNSRule 8.3- Microemissive Displ
18th Aug 20087:49 amRNSEPT Disclosure
13th Aug 20087:50 amRNSEPT Disclosure
6th Aug 200811:52 amRNSRule 8.3- Microemissive Displ
6th Aug 20087:42 amRNSEPT Disclosure
4th Aug 20089:09 amRNSEPT Disclosure
1st Aug 200812:20 pmRNSTrading Update and Strategic
21st Jul 20084:36 pmRNSHolding(s) in Company
16th Jul 20089:47 amRNSHolding(s) in Company
11th Jul 20087:00 amRNSMOU Signed
4th Jul 20089:40 amRNSHolding(s) in Company
2nd Jul 20087:00 amRNSMOU Signed
18th Jun 20082:09 pmRNSAnnual Report and Accounts
16th May 20082:15 pmRNSDirector/PDMR Shareholding
15th May 20083:44 pmRNSHolding(s) in Company
13th May 20086:09 amRNSTrading Statement
7th Apr 20083:26 pmRNSHolding(s) in Company
7th Apr 20083:03 pmRNSDirectorate Change-Amendment
7th Apr 20082:38 pmRNSDirectorate Change
14th Mar 20081:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.